We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
+26.49%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$988M
AUM Growth
+$129M
Cap. Flow
+$16.3M
Cap. Flow %
1.65%
Top 10 Hldgs %
50.06%
Holding
77
New
6
Increased
26
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$29.2M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$8.2M
3
LABU icon
Direxion Daily S&P Biotech Bull 3X ETF
LABU
+$7.86M
4
TMDX icon
Transmedics
TMDX
+$6.69M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$5.9M

Top Sells

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$12.6M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$10.6M
3
KRYS icon
Krystal Biotech
KRYS
+$7.45M
4
CDXS icon
Codexis
CDXS
+$7.17M
5
CDNA icon
CareDx
CDNA
+$4.87M

Sector Composition

Rank Sector Weight
1 Healthcare 86.29%
2 Communication Services 9.04%
3 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
51
United Therapeutics
UTHR
$25.8B
$516K 0.05%
2,466
– –
ABBV icon
52
AbbVie
ABBV
$443B
$502K 0.05%
3,740
– –
MCK icon
53
McKesson
MCK
$100B
$457K 0.05%
1,346
– –
BDX icon
54
Becton Dickinson
BDX
$45.6B
$421K 0.04%
1,888
– –
GILD icon
55
Gilead Sciences
GILD
$162B
$414K 0.04%
6,705
– –
WAT icon
56
Waters Corp
WAT
$37B
$414K 0.04%
1,536
– –
NVST icon
57
Envista
NVST
$4.44B
$387K 0.04%
11,793
– –
HOLX
58
DELISTED
Hologic
HOLX
$377K 0.04%
5,845
– –
ITGR icon
59
Integer Holdings
ITGR
$4.12B
$364K 0.04%
5,846
– –
JNJ icon
60
Johnson & Johnson
JNJ
$618B
$353K 0.04%
2,161
– –
PRGO icon
61
Perrigo
PRGO
$1.4B
$350K 0.04%
9,823
– –
NUVA
62
DELISTED
NuVasive, Inc.
NUVA
$344K 0.03%
7,850
– –
TAK icon
63
Takeda Pharmaceutical
TAK
$54.6B
$332K 0.03%
25,630
– –
BAX icon
64
Baxter International
BAX
$13.5B
$319K 0.03%
5,929
– –
ICUI icon
65
ICU Medical
ICUI
$4.21B
$307K 0.03%
2,039
– –
GSK icon
66
GSK
GSK
$104B
$296K 0.03%
10,058
-1
-0% -$38
AVTR icon
67
Avantor
AVTR
$9.32B
$286K 0.03%
14,596
– –
SYNH
68
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$270K 0.03%
5,736
– –
SNY icon
69
Sanofi
SNY
$103B
$253K 0.03%
6,650
– –
SONX
70
DELISTED
Sonendo, Inc.
SONX
$239K 0.02%
+223,393
New +$325K
HLN icon
71
Haleon
HLN
$43.5B
$77K 0.01%
+12,574
New +$81.4K
CDXS icon
72
Codexis
CDXS
$151M
– –
-685,213
Closed -$7.17M
IWO icon
73
iShares Russell 2000 Growth ETF
IWO
$14.3B
– –
-13,242
Closed -$2.73M
UHS icon
74
Universal Health Services
UHS
$10.2B
– –
-2,050
Closed -$206K
SIEN
75
DELISTED
Sientra, Inc.
SIEN
– –
-143,139
Closed -$1.2M
1 2
3
4

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, First Light Asset Management held 77 positions worth $988M, up 15% from $859M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

First Light Asset Management's Q3 2022 filing shows 6 new, 26 increased, 14 reduced and 6 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M. The largest sale was Prothena Corp, an estimated $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 87% a quarter earlier, followed by Communication Services and Energy.

  • First Light Asset Management's largest Q3 2022 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 1,054,985 shares worth $26.5M.
  • First Light Asset Management added most to Karuna Therapeutics, Inc. Common Stock in Q3 2022, an estimated $8.2M increase.
  • First Light Asset Management's biggest Q3 2022 reduction was Prothena Corp, cutting an estimated $12.6M.
  • First Light Asset Management fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $10.6M.
  • First Light Asset Management's ten largest holdings make up 50% of its $988M portfolio in Q3 2022.
  • First Light Asset Management opened 6 new positions and closed 6 in Q3 2022.
  • First Light Asset Management's portfolio value rose 15% quarter-over-quarter to $988M.

Based on First Light Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.